These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 23603311)
41. Long Noncoding RNA loc285194 Expression in Human Papillomavirus-Positive and -Negative Cervical Squamous Cell Carcinoma, C33A, and SiHa Cells and Transforming Growth Factor-β1. Wang J; Zhang Y; Lin R; Mao B; Wang W; Bai Y; He W; Liu Q Med Sci Monit; 2019 Nov; 25():9012-9018. PubMed ID: 31774069 [TBL] [Abstract][Full Text] [Related]
42. Association of TNF-α-308G/A and IL-18 Polymorphisms with risk of HPV infection among sexually active women in Burkina Faso. Traore IMA; Zohoncon TM; Djigma FW; Compaore TR; Traore Y; Simpore J Biomol Concepts; 2020 Apr; 11(1):97-101. PubMed ID: 32304293 [TBL] [Abstract][Full Text] [Related]
43. Interleukin-1 beta-511 polymorphism and risk of cervical cancer. Kang S; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP J Korean Med Sci; 2007 Feb; 22(1):110-3. PubMed ID: 17297261 [TBL] [Abstract][Full Text] [Related]
44. Association between genetic polymorphisms in the promoters of let-7 and risk of cervical squamous cell carcinoma. Liu J; Ni S Gene; 2018 Feb; 642():256-260. PubMed ID: 29154871 [TBL] [Abstract][Full Text] [Related]
45. Genetic variation in RTN4 3'-UTR and susceptibility to cervical squamous cell carcinoma. Shi S; Zhou B; Wang Y; Chen Y; Zhang K; Wang K; Quan Y; Song Y; Rao L; Zhang L DNA Cell Biol; 2012 Jun; 31(6):1088-94. PubMed ID: 22320844 [TBL] [Abstract][Full Text] [Related]
46. A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. Hardikar S; Johnson LG; Malkki M; Petersdorf EW; Galloway DA; Schwartz SM; Madeleine MM Gynecol Oncol; 2015 Oct; 139(1):90-6. PubMed ID: 26241630 [TBL] [Abstract][Full Text] [Related]
47. NFKB1/NFKBIa polymorphisms are associated with the progression of cervical carcinoma in HPV-infected postmenopausal women from rural area. Pallavi S; Anoop K; Showket H; Alo N; Mausumi B Tumour Biol; 2015 Aug; 36(8):6265-76. PubMed ID: 25773394 [TBL] [Abstract][Full Text] [Related]
48. The interaction between RAGE gene polymorphisms and HPV infection in determining the susceptibility of cervical cancer in a Chinese population. Xu Q; Xue F; Yuan B; Zhang L; Li J; He Z Cancer Biomark; 2012; 11(4):147-53. PubMed ID: 23144152 [TBL] [Abstract][Full Text] [Related]
49. IL-6 597A/G (rs1800797) and 174G/C (rs1800795) Gene Polymorphisms in the Development of Cervical Cancer in Lithuanian Women. Vitkauskaite A; Celiesiute J; Juseviciute V; Jariene K; Skrodeniene E; Samuolyte G; Nadisauskiene RJ; Vaitkiene D Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684062 [TBL] [Abstract][Full Text] [Related]
50. LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells. Zhang Y; Na R; Wang X BMC Cancer; 2019 Nov; 19(1):1052. PubMed ID: 31694597 [TBL] [Abstract][Full Text] [Related]
51. An insertion/deletion polymorphism at miRNA-122 binding site in the IL1A is associated with a reduced risk of cervical squamous cell carcinoma. Huang J; Ni S; Li D; He Y Genet Test Mol Biomarkers; 2015 Jun; 19(6):331-4. PubMed ID: 25955681 [TBL] [Abstract][Full Text] [Related]
52. CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis. Okuyama NCM; Cezar-Dos-Santos F; Trugilo KP; Esposito A; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB J Cancer Res Clin Oncol; 2022 Apr; 148(4):793-802. PubMed ID: 35083551 [TBL] [Abstract][Full Text] [Related]
53. Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study. Zhu M; Li X; Feng Y; Jia T; Li S; Gong L; Dong S; Kong X; Sun L BMC Cancer; 2023 Sep; 23(1):845. PubMed ID: 37691121 [TBL] [Abstract][Full Text] [Related]
54. Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Ivansson EL; Gustavsson IM; Magnusson JJ; Steiner LL; Magnusson PK; Erlich HA; Gyllensten UB Int J Cancer; 2007 Dec; 121(11):2451-7. PubMed ID: 17688234 [TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus and host genetic polymorphisms in carcinogenesis: a systematic review and meta-analysis. Habbous S; Pang V; Xu W; Amir E; Liu G J Clin Virol; 2014 Oct; 61(2):220-9. PubMed ID: 25174543 [TBL] [Abstract][Full Text] [Related]
56. No association of the POLI Thr706Ala polymorphism with the risk of cervical carcinoma. Zhang J; Ye F; Cheng Q; Shen J; Chen H Eur J Surg Oncol; 2008 Aug; 34(8):916-920. PubMed ID: 18194848 [TBL] [Abstract][Full Text] [Related]
57. Use of Single Cell Transcriptomic Techniques to Study the Role of High-Risk Human Papillomavirus Infection in Cervical Cancer. Meng L; Chen S; Shi G; He S; Wang Z; Shen J; Wang J; Sooranna SR; Zhao J; Song J Front Immunol; 2022; 13():907599. PubMed ID: 35769468 [TBL] [Abstract][Full Text] [Related]
58. A case of HPV-53-related cervical cancer in an elderly patient. Lieveld M; Padalko E; Praet M; Vanden Broeck D Clin Interv Aging; 2014; 9():1933-4. PubMed ID: 25419122 [No Abstract] [Full Text] [Related]
59. The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa. Chattopadhyay K; Williamson AL; Hazra A; Dandara C BMC Cancer; 2015 Oct; 15():680. PubMed ID: 26458812 [TBL] [Abstract][Full Text] [Related]
60. Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Johnson LG; Schwartz SM; Malkki M; Du Q; Petersdorf EW; Galloway DA; Madeleine MM Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):199-207. PubMed ID: 21071541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]